
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-0706:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013481 |
| 2023-07-1316:41 ET | 8-K | 5.07 Shareholder vote results | 0001558370-23-011868 |
| 2023-06-2907:24 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-23-011550 |
| 2023-05-3007:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-010565 |
| 2023-05-1817:00 ET | DEF 14A | Proxy statementPeriod 2023-06-28 | 0001104659-23-062301 |
| 2023-05-1806:57 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-010154 |
| 2023-05-1006:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-008953 |
| 2023-05-0506:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-008188 |
| 2023-05-0416:30 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-008132 |
| 2023-05-0407:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-007978 |
| 2023-05-0106:47 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001558370-23-007386 |
| 2023-02-2706:48 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-002104 |
| 2023-02-2706:45 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-002102 |
| 2023-02-2706:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-002100 |
| 2023-02-2409:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-001975 |
| 2023-01-0306:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-000003 |
| 2022-12-2716:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-018990 |
| 2022-12-2116:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-018894 |
| 2022-11-1407:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017554 |
| 2022-11-1407:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-017549 |
| 2022-09-0116:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-014127 |
| 2022-08-1507:09 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013560 |
| 2022-08-1507:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-013557 |
| 2022-06-3017:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-010491 |
| 2022-05-2616:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-009406 |
| 2022-05-1607:09 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-008847 |
| 2022-05-1607:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-008843 |
| 2022-05-0206:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-006566 |
| 2022-04-2916:36 ET | DEF 14A | Proxy statementPeriod 2022-06-30 | 0001104659-22-053664 |
| 2022-04-0406:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-005043 |
| 2022-03-3107:12 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-004823 |
| 2022-03-3107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-004821 |
| 2022-02-2409:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-001858 |
| 2021-12-2206:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-21-016986 |
| 2021-11-2416:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-21-016327 |
| 2021-11-1507:19 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015862 |
| 2021-11-1507:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-015857 |
| 2021-10-1206:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-013109 |
| 2021-09-3016:30 ET | DEF 14A | Proxy statementPeriod 2021-11-24 | 0001558370-21-012901 |
| 2021-08-2607:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001558370-21-012078 |
| 2021-08-1607:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-011752 |
| 2021-08-1607:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-011750 |
| 2021-08-1307:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-011566 |
| 2021-07-0716:31 ET | 8-K | 5.07 Shareholder vote results | 0001558370-21-008801 |
| 2021-07-0217:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-088982 |
| 2021-06-3017:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-008725 |
| 2021-06-0416:30 ET | DEF 14A | Proxy statementPeriod 2021-07-07 | 0001558370-21-008019 |
| 2021-06-0207:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-007920 |
| 2021-05-1407:04 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-007157 |
| 2021-05-1406:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-007154 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.